Prostate Cell News Volume 11.41 | Oct 30 2020

    0
    15







    2020-10-30 | PCN 11.41


    Prostate Cell News by STEMCELL Technologies
    Vol. 11.41 – 30 October, 2020
    TOP STORY

    A Broad Response to Intracellular Long-Chain Polyphosphate in Human Cells

    Polyphosphates (polyPs) are long chains of inorganic phosphates linked by phosphoanhydride bonds. They are found in all kingdoms of life, playing roles in cell growth, infection, and blood coagulation. Scientists demonstrated that internally produced polyP could activate diverse signaling pathways in human cells.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Subscribe to Organoid News to stay current with the latest organoid research.
    PUBLICATIONSRanked by the impact factor of the journal

    Sox2 Is Necessary for Androgen Ablation-Induced Neuroendocrine Differentiation from Pten Null Sca-1+ Prostate Luminal Cells

    Researchers provide direct genetic evidence that Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation of Pten null prostate adenocarcinoma. They corroborated that the lineage status of the prostate cancer cells was a determinant for its propensity to exhibit lineage plasticity, and supported that the intrinsic features of cell-of-origin for prostate cancers could dictate their clinical behaviors.
    [Oncogene]

    Abstract

    A Multifunctional LNA Oligo-Based Strategy Blocks Androgen Receptor Expression and Transactivation Activity in Prostate Cancer Cells

    The androgen receptor (AR) plays a critical role in the development of prostate cancer (PCa) through the activation of androgen-induced cellular proliferation genes. Using tailor-made splice switching locked nucleic acid (LNA) oligos, scientists successfully redirected splicing of the AR pre-mRNA and destabilized the transcripts via the introduction of premature stop codons.
    [Molecular Therapy-Nucleic Acids]

    AbstractGraphical Abstract

    Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated from Patient-Derived Organoids

    The authors report the isolation and characterization of novel patient-derived prostate epithelial cells from an organoids culture system. They also assessed the role of epidermal growth factor in culturing those cells.
    [Frontiers in Cell and Developmental Biology]

    Full Article

    Neddylation Blockade Induces HIF-1α Driven Cancer Cell Migration via Upregulation of ZEB1

    Scientists report that inhibiting neddylation activated the hypoxia-inducible factor 1α (HIF-1α) through the PI3K-Akt pathway, which eventually regulated the epithelial to mesenchymal transition-activator zinc finger E-box binding homeobox 1 (ZEB1) in various cancer cell lines.
    [Scientific Reports]

    Full Article

    A Low pKa Ligand Inhibits Cancer-Associated Pain in Mice by Activating Peripheral Mu-Opioid Receptors

    Investigators explored the pH-dependency of NFEPP binding to mouse brain peripheral mu-opioid receptors and assessed the antihyperalgesic effects of NFEPP in murine models of bone cancer-induced pain. They also evaluated mice treated with fibrosarcoma NCTC 2472 cells or RM1 cells derived from prostate carcinoma.
    [Scientific Reports]

    Full Article

    Virtual Conference Exhibition: Organoids
    REVIEWS

    Emerging Players in Prostate Cancer–Bone Niche Communication

    The authors highlight the emerging role of prostate cancer (PCa)-derived extracellular vesicles in reprogramming osteoblasts and support of premetastatic niche formation. They also develop the concept of cancer-associated osteoblasts and outline the potential of PCa cells to acquire an osteoblastic phenotype, termed osteomimicry, as two strategies that PCa utilizes to create a favorable protected niche.
    [Trends in Cancer]

    Full Article

    Genetic Aberrations in DNA Repair Pathways: A Cornerstone of Precision Oncology in Prostate Cancer

    Investigators summarize the current knowledge regarding the biology and clinical implications of DNA damage response and repair defects in prostate cancer, and outline how this evidence is prompting a change in the treatment landscape of the disease.
    [British Journal of Cancer]

    Full Article

    INDUSTRY AND POLICY NEWS

    Treadwell Announces Initiation of New Clinical Trial of CFI-400945 in Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

    The Canadian Cancer Trials Group announced the commencement of a new sub-study evaluating CFI-400945, an oral, first-in-class inhibitor of Polo-like Kinase 4, in patients with mCRPC.
    [Treadwell Therapeutics (Businesswire, Inc.)]

    Press Release

    FEATURED EVENT

    Keystone Symposia: Single Cell Biology

    March 17 – March 19, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Senior Group Leader – Rare Cancers

    IRCCS Candiolo Cancer Institute – Candiolo, Italy

    Endowed Chair & Multiple Assistant/Associate Faculty Positions

    Lerner Research Institute – Cleveland, Ohio, United States

    Postdoctoral Fellow – Breast and Colorectal Cancer

    Dalhousie University- Halifax, Nova Scotia, Canada

    Postdoctoral Fellow – Prostate Cancer Research

    City of Hope – Duarte, California, United States

    Postdoctoral Position – Clinical AI and Data Science

    University of Southern Denmark – Odense M, Denmark

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter